These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17514734)

  • 21. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; Stigter RL; van Wering ER; Janka-Schaub GE; Slater R; Pieters R
    Blood; 2003 Apr; 101(7):2743-7. PubMed ID: 12433682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
    Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
    Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the gut microbial community and genes in children with differing levels of change in serum asparaginase activity during pegaspargase treatment for acute lymphoblastic leukemia.
    Dunn KA; Connors J; Bielawski JP; Nearing JT; Langille MGI; Van Limbergen J; Fernandez CV; MacDonald T; Kulkarni K
    Leuk Lymphoma; 2021 Apr; 62(4):927-936. PubMed ID: 33258724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asparagine synthetase chemotherapy.
    Richards NG; Kilberg MS
    Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL.
    Akahane K; Kimura S; Miyake K; Watanabe A; Kagami K; Yoshimura K; Shinohara T; Harama D; Kasai S; Goi K; Kawai T; Hata K; Kiyokawa N; Koh K; Imamura T; Horibe K; Look AT; Minegishi M; Sugita K; Takita J; Inukai T
    Blood Adv; 2022 Jan; 6(1):212-224. PubMed ID: 34535013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells.
    Ikeuchi H; Ahn YM; Otokawa T; Watanabe B; Hegazy L; Hiratake J; Richards NG
    Bioorg Med Chem; 2012 Oct; 20(19):5915-27. PubMed ID: 22951255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
    Serravalle S; Bertuccio SN; Astolfi A; Melchionda F; Pession A
    Biomed Res Int; 2016; 2016():1985750. PubMed ID: 28003999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia.
    Bushman JE; Palmieri D; Whinna HC; Church FC
    Leuk Res; 2000 Jul; 24(7):559-65. PubMed ID: 10867129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective apoptosis of natural killer-cell tumours by l-asparaginase.
    Ando M; Sugimoto K; Kitoh T; Sasaki M; Mukai K; Ando J; Egashira M; Schuster SM; Oshimi K
    Br J Haematol; 2005 Sep; 130(6):860-8. PubMed ID: 16156856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
    Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
    Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.
    Watanabe A; Miyake K; Nordlund J; Syvänen AC; van der Weyden L; Honda H; Yamasaki N; Nagamachi A; Inaba T; Ikawa T; Urayama KY; Kiyokawa N; Ohara A; Kimura S; Kubota Y; Takita J; Goto H; Sakaguchi K; Minegishi M; Iwamoto S; Shinohara T; Kagami K; Abe M; Akahane K; Goi K; Sugita K; Inukai T
    Blood; 2020 Nov; 136(20):2319-2333. PubMed ID: 32573712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.
    Zhang B; Dong LW; Tan YX; Zhang J; Pan YF; Yang C; Li MH; Ding ZW; Liu LJ; Jiang TY; Yang JH; Wang HY
    Br J Cancer; 2013 Jul; 109(1):14-23. PubMed ID: 23764751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line.
    Costa IM; Effer B; Costa-Silva TA; Chen C; Ciccone MF; Pessoa A; Dos Santos CO; Monteiro G
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of genetic variants in asparaginase pathway on the susceptibility to asparaginase-related toxicity and patients' outcome in childhood acute lymphoblastic leukemia.
    Youssef YH; Makkeyah SM; Soliman AF; Meky NH
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):313-321. PubMed ID: 33959786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Declined asparagine synthetase mRNA expression and enhanced sensitivity to asparaginase in HL-60 cells committed to monocytic differentiation.
    Hashimoto K; Suzuki F; Sakagami H
    Anticancer Res; 2009 Apr; 29(4):1303-8. PubMed ID: 19414379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.
    Pastorczak A; Fendler W; Zalewska-Szewczyk B; Górniak P; Lejman M; Trelińska J; Walenciak J; Kowalczyk J; Szczepanski T; Mlynarski W;
    Leuk Res; 2014 Feb; 38(2):180-3. PubMed ID: 24268318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
    Nishikawa G; Kawada K; Hanada K; Maekawa H; Itatani Y; Miyoshi H; Taketo MM; Obama K
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
    Jarrar M; Gaynon PS; Periclou AP; Fu C; Harris RE; Stram D; Altman A; Bostrom B; Breneman J; Steele D; Trigg M; Zipf T; Avramis VI
    Pediatr Blood Cancer; 2006 Aug; 47(2):141-6. PubMed ID: 16425271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells.
    He Y; Li B; Luo C; Shen S; Chen J; Xue H; Tang J; Gu L
    J Huazhong Univ Sci Technolog Med Sci; 2011 Apr; 31(2):159-163. PubMed ID: 21505976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling.
    Mukherjee A; Ahmed N; Rose FT; Ahmad AN; Javed TA; Wen L; Bottino R; Xiao X; Kilberg MS; Husain SZ
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):1-13. PubMed ID: 31421261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.